New Zealand's Ability To Monitor Geohazards Weakened By Science Job Cuts
Press Release – PSA
The National GeoHazard Monitoring Centre, operated by GNS Science, provides round the clock monitoring of potential tsunamis, earthquakes, volcanic eruptions and landslides, and was set up after the Kaikoura Earthquake in 2016.
The centre providing 24/7 monitoring of geohazards will have to close at times as Government cuts force the centre workforce to be cut to the bone.
The National GeoHazard Monitoring Centre, operated by GNS Science, provides round the clock monitoring of potential tsunamis, earthquakes, volcanic eruptions and landslides, and was set up after the Kaikoura Earthquake in 2016.
Last year GNS Science announced plans to cut a quarter of the 20 strong team of Geohazard Analysts by attrition following funding cuts. Yesterday, with 18 of the team left, it called for voluntary redundancies and indicated that forced redundancies could follow if sufficient voluntary redundancies are not agreed.
'Cutting the team to the bone means there is a high chance the centre will close at times when a team member falls sick or is unavailable for whatever reason – how is this keeping New Zealanders safe?' said Fleur Fitzsimons, National Secretary for the Public Service Association for Te Pūkenga Here Tikanga Mahi.
Analysts work in teams of four, that is falling to three, but there must be at least two on each monitoring shift raising the risk of the centre closing due to staff absences.
'The Government needs to explain to New Zealanders why it views that this service is not as important as it was two years ago, before its funding cuts.
'Geohazard Analysts play a critical role in reviewing earthquake measurements to determine things like the magnitude and location of earthquakes and provide science advice to our emergency management services.
'The Government's decisions mean that this critical information may not be available to emergency management in times of need when lives are at risk. This is reckless for a country so vulnerable to geohazard risks like earthquakes and eruptions.
'This government does not value the role of science as we have seen with more than 400 jobs cuts throughout the sector, and a restructure announced this year with no new funding.
'The undermining of the National GeoHazard Monitoring Centre is yet another sad example of the Government's short-sighted cuts that we have seen across the public sector with little regard to the impacts on New Zealanders.'
Background
In September last year GNS Science announced plans to axe 59 roles, 10% of its workforce following Government funding cuts. The cuts shocked the international science community – 85 scientists from seven countries wrote an open letter to the Government stating that the cuts risk 'compromising essential geoscientific expertise and partnerships needed to address geohazards risks, which is critical for a country whose economy and community safety is so vulnerable to earthquakes, volcanoes, and climate change'.
Note:
The Public Service Association Te Pūkenga Here Tikanga Mahi is Aotearoa New Zealand's largest trade union, representing and supporting more than 95,000 workers across central government, state-owned enterprises, local councils, health boards and community groups.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scoop
2 hours ago
- Scoop
Successful Childhood Immunisation Programme Delivering Results
Minister of Health A successful programme to help Māori health providers lift childhood immunisation rates will be renewed, Health Minister Simeon Brown says. "The Immunising our Tamariki programme, originally launched in 2023 by Hon Dr Shane Reti, invested $50 million in Māori health providers to deliver targeted, community-based immunisation outreach. It aims to lift childhood immunisation rates for babies and children who may not be reached through traditional health channels such as GPs or pharmacies." 'Since March 2024, the programme has delivered 41,719 scheduled childhood immunisations for children under 24 months, including 3,301 in May – the highest monthly total since it began,' Mr Brown says. 'In total, more than 132,000 vaccinations have been administered through the programme, with a record 18,555 given in April 2025 alone as part of preparations for winter – including influenza and other immunisations. It's a clear example of how backing local health providers and frontline workers delivers better outcomes for the communities they know best. 'The Immunising our Tamariki programme focuses on reaching children and families who are yet to receive their immunisation through traditional pathways such as GP practices, particularly in communities with historically low immunisation rates. 'We know we need to significantly lift immunisation rates for Māori to meet the Government's target of 95 per cent of children being fully immunised by 24 months of age. Targeted, localised outreach services are critical to achieving that goal. 'About 40 per cent of people immunised through the programme are also non-Māori, reflecting the essential role that community providers play in delivering low-cost, trusted health services for all New Zealanders.' As part of the programme's renewal to 30 June 2026, Health New Zealand will implement several changes to maximise its impact: All funding will go directly to frontline service delivery and qualified immunisation staff. Newly commissioned services must include clinical capacity to vaccinate – such as authorised vaccinators and cold chain infrastructure – so new providers can begin immunising immediately. Support will continue for Māori health providers to build trust and momentum in communities with high-needs, building on the groundwork laid during the COVID-19 response. 'These improvements will help deliver tens of thousands more immunisations in the year ahead, while relieving pressure on GPs and hospitals. 'One of the most important things we can do to protect children and families is to stay up to date with immunisations. This programme is a smart, targeted way of doing just that,' Mr Brown says.
Otago Daily Times
20 hours ago
- Otago Daily Times
Pharmac considers extension to free vaccination programme
By Victor Waters of RNZ Pharmac says it's exploring ways to extend a free meningoccocal B vaccine programme, with an estimated 100,000 eligible pre-schoolers still not protected. Meningitis prevention advocates have pressured health officials to continue the campaign, which is due to end on August 31. Pharmac pharmaceuticals director Geraldine MacGibbon said Pharmac funds the meningococcal B vaccine for all children under the age of one. "In March 2023, Pharmac funded a catch-up programme for children under the age of five to better protect young New Zealanders from meningococcal B. "We understand that people are keen to see the catch-up period extended and we are actively exploring options for this." "We will keep interested groups, including the Meningitis Foundation, informed about any updates," MacGibbon said. According to the Meningitis Foundation Aotearoa New Zealand, meningococcal bacteria can cause meningococcal meningitis - inflammation of the meninges, the membrane lining of the brain and spinal cord - and/or septicaemia (blood poisoning). Foundation chair Gerard Rushton said the meningococcal B vaccination programme was initiated after a submission the foundation made to Parliament and an application to Pharmac. He said more than 400,000 doses were given out in the first 12 months of the campaign. "We're calling on Health New Zealand and the government to actually continue this programme, because we know it works. We know it will save lives. "We know it's going to take pressure off the already-stretched health system. "What we're saying is this campaign has been very successful and it's been proven that people want it, but there's still 100,000 of our tamariki that haven't been protected, so we're calling them to keep this programme going. "We're really concerned that this large sector of our community are going to miss out. The vaccination rates for our young are still far too low, but we need them to extend this programme, because we need to protect those 100,000 of our children who are still unvaccinated." A Health New Zealand spokesperson said it was are "responsible for the implementation of the programme". "Pharmac funds the meningococcal B catch-up programme and set the timeframe from 1 March 2023 to 31 August 2025." A Health New Zealand spokesperson said, as of 9 June 2025, 84 percent of eligible children under 15 months had at least one dose of the meningococcal B vaccine. "Whānau can access the meningococcal B vaccines from a range of places, including general practice, hauora Māori and Pacific providers, with many Wellchild Tamariki Ora Services, including Whānau Āwhina Plunket, offering immunisations. "There are also more than 122 pharmacies now offering the vaccine for children aged from three years. "The meningococcal B vaccination is a part of the national immunisation schedule. "As a part of the Government's Health Target, we are focused on lifting childhood immunisation rates and we are making good progress towards this goal," said the spokesperson. Meningitis Foundation Aotearoa New Zealand chair Gerard Rushton said his organisation didn't see a reason for the catch-up programme to be discontinued. "Māori and Pasifika are 4-5 times more likely to catch meningitis than the European population, so they are a higher risk at the moment. We struggle to understand why there's a vaccination programme at the moment that actually discriminates against them. "The full vaccination programme was that the babies are free, there was a catch-up programme for 13-month to 5-year-olds, and that first-year students in boarding schools, halls of residence, barracks or prisons could get it free." "We feel that discriminates against the biggest at-risk group we've got, which is our Māori and Pasifika, because they're under-represented at halls of residence and boarding schools," he said.
Scoop
a day ago
- Scoop
New And Improved Radiology Services For Auckland City Hospital
Press Release – New Zealand Government Minister of Health Health Minister Simeon Brown has today announced funding for the first stage of a major project to upgrade and expand interventional radiology services at Auckland City Hospital. 'This project will significantly improve access to radiology services for patients across Auckland and beyond,' Mr Brown says. 'A $41.2 million investment will fund the initial phase of the project – including construction of a fourth interventional neuroradiology operating theatre equipped with state-of-the-art imaging technology and enhanced support services. 'Investing in modern health infrastructure is a priority for this Government to ensure New Zealanders can access timely, high-quality care when they need it. 'The existing interventional radiology facility is outdated and no longer suitable for the advanced imaging equipment clinicians need. Redesigning the space will enable the use of modern technology and support more sophisticated models of care that meet the increasing complexity of patient needs over the coming decade.' The expansion, expected to be operational by early 2027, will significantly boost capacity for emergency stroke interventions and complex neuroradiology procedures – including specialist treatments for children from across the country. Stage 1 will also deliver: A replacement fluoroscopy room An interventional ultrasound room A new biplane imaging machine An expanded short-stay ward The funding will also support development of a second business case to fully complete a new, purpose-built interventional radiology suite – strengthening services not only for Auckland, but for patients nationwide who require advanced interventional care. 'This project will help reduce wait times for interventional radiology procedures, which play a critical role in diagnosing and treating life-threatening conditions and guiding decisions for further specialist care. 'Better access to interventional radiology means faster diagnoses, less invasive treatments, and improved outcomes for patients,' Mr Brown says.
